SaeR as a novel target for antivirulence therapy against Staphylococcus aureus

SaeR as a novel target for antivirulence therapy against Staphylococcus aureus

ABSTRACTStaphylococcus aureus is a major human pathogen responsible for a wide range of clinical infections. SaeRS is one of the two-component systems in S. aureus that modulate multiple virulence factors. Although SaeR is required for S. aureus to develop an infection, inhibitors have not been repo...

Full description

Bibliographic Details
Main Authors: Peng Gao, Yuanxin Wei, Suying Hou, Pok-Man Lai, Han Liu, Sherlock Shing Chiu Tai, Victor Yat Man Tang, Pradeep Halebeedu Prakash, Kong-Hung Sze, Jonathan Hon Kwan Chen, Hongzhe Sun, Xuechen Li, Richard Yi-Tsun Kao
Format: Article
Language:English
Published: Taylor & Francis Group 2023-12-01
Series:Emerging Microbes and Infections
Subjects:
S. aureus
SaeR
virulence
inhibitor
target
Online Access:https://www.tandfonline.com/doi/10.1080/22221751.2023.2254415

Internet

https://www.tandfonline.com/doi/10.1080/22221751.2023.2254415

Similar Items